ArticleScientific reports2025
Assessing the effect of social contact structure on the impact of pneumococcal conjugate vaccines.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although pneumococcal conjugate vaccines (PCVs) have greatly reduced diseases caused by vaccine-targeted serotypes (VT) of Streptococcus pneumoniae, vaccine impact may be eroded by the increase in rates of disease caused by non-vaccine serotypes (NVT). Here, we investigated the effect of social contact patterns on the dynamics of vaccine impact in carriage. We developed a neutral, age-structured, Susceptible-Colonized model incorporating VT-NVT co-colonization and verified it against real-world carriage data in children. Using social contact matrices from 34 countries, we assessed the impact of contact patterns on the time required to eliminate VT in a given age group (defined here as the time needed for the relative proportion of VT in overall carriage to drop by 95% after the introduction of vaccination). Finally, we quantified the contribution of various parameters-such as vaccine efficacy, coverage, immunity waning, and population susceptibility-to the dynamics of VT elimination. Our model recapitulated the observed decline of VT carriage and showed that varying the contact structure alone led to different time-to-elimination (3.8-6 years). We found that higher total contact rate and assortativity in children under 5 accelerated VT elimination. Additionally, higher vaccine efficacy and coverage, and slower immunity waning led to shorter time-to-elimination. These findings illuminate the mechanisms controlling the dynamics of vaccine impact and may help predict the impact of PCVs in communities with different contact patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.